Traditional Chinese Medicine as an Adjunct in Cancer Treatment: The Real Value from an Evidence-Based Perspective

Introduction

When diagnosed with cancer, many patients and their families ask: "Besides surgery, chemotherapy, and radiotherapy, can Traditional Chinese Medicine help?" Behind this question lies both trust in traditional wisdom and anxiety about the limitations of modern medicine. In fact, TCM does play a role in the comprehensive management of cancer, but not as a replacement—rather as an adjunct. From the perspective of Evidence-Based Medicine, the value and risks of TCM coexist. Based on international authoritative research, this article sorts out its real efficacy and potential pitfalls for you.

The Role of TCM in Cancer Treatment: Adjunct, Not Alternative

The gold standard for cancer treatment remains surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy. The role of TCM is support and regulation, aimed at reducing treatment side effects, improving quality of life, and potentially enhancing efficacy. For example, acupuncture has been recommended by the American Society of Clinical Oncology (ASCO) as an effective adjunctive measure for chemotherapy-induced nausea and vomiting (evidence level: moderate). A Cochrane review (2017) including 41 randomized controlled trials confirmed that acupuncture (especially electroacupuncture) can reduce the incidence of post-chemotherapy vomiting by approximately 30%.

Regarding herbal medicine, certain formulas such as Astragalus (Huangqi) and Angelica (Danggui) have shown potential in Chinese domestic studies to alleviate fatigue and enhance immune function, but high-quality international research remains limited. The key principle is: TCM cannot replace standard treatment. If patients delay or abandon radiotherapy or chemotherapy due to trust in herbal medicine, the consequences could be disastrous.

Evidence-Based Evidence: Which Therapies Have Data Support?

Currently, the areas with the strongest evidence focus on symptom management:

Chemotherapy-induced nausea and vomiting: Acupuncture (at the Neiguan point) and acupressure have been recommended by guidelines; herbal medicine (such as Xiao Ban Xia Tang) has preliminary evidence but requires large-sample validation.

Cancer-related fatigue: A randomized trial published in the Journal of Clinical Oncology in 2021 showed that an oral liquid of Astragalus combined with Angelica significantly improved fatigue scores (improvement of approximately 20%), but the study was small (n=120).

Neuropathy: For chemotherapy-induced peripheral neuropathy, acupuncture and herbal topical washes (such as with Cinnamomum cassia twig and safflower) have shown relief of pain and numbness in preliminary studies, but the evidence level is low.

It is noteworthy that direct effects of TCM on tumor shrinkage or survival currently lack high-quality evidence. Any claim of "pure herbal cure for cancer" is unscientific and should be regarded with caution.

Potential Risks: Hepatotoxicity and Drug Interactions That Cannot Be Ignored

TCM is not "naturally harmless." Risks mainly arise from three aspects:

Hepatotoxicity: Certain herbal components (such as Polygonum multiflorum, Tripterygium wilfordii, and Aristolochia) can cause severe liver or kidney damage. The international liver disease database (LiverTox) has recorded multiple related cases. If a patient's liver function is already impaired by chemotherapy, the added risk is higher.

Drug interactions: Herbal medicines may affect the hepatic CYP450 enzyme system, altering the plasma concentrations of chemotherapy drugs (such as cyclophosphamide and tamoxifen), or enhancing the effects of anticoagulants (such as warfarin), leading to bleeding risk. For example, ginseng and ginkgo can inhibit platelet aggregation.

Heavy metal contamination: Some proprietary Chinese medicines may contain mercury, lead, etc., which are harmful to health with long-term use.

Therefore, any herbal medicine use must be reported to the oncologist before initiation, and liver and kidney function should be monitored. Never purchase products from unregulated sources.

Practical Integration Strategies for International Patients

If you are considering TCM as an adjunctive treatment, please follow these steps:

Consult your primary physician: Before starting any TCM therapy, make your primary oncologist your first point of contact. The doctor can assess potential interactions and arrange necessary liver and kidney function tests.

Choose reputable institutions: If in China, it is recommended to choose the TCM department or integrated Chinese-Western medicine department of a tertiary hospital, rather than private clinics. Abroad, look for licensed acupuncturists (such as those certified by NCCAOM).

Document and report: Keep detailed records of all herbal medicines you take, acupuncture sessions, and any discomfort, and share them regularly with your medical team.

Set clear goals: Focus goals on symptom relief and quality of life improvement, rather than tumor shrinkage. If results are unsatisfactory, adjust the plan promptly.

Our medical services cover multidisciplinary consultations and can help you integrate Chinese and Western medical resources; if needed, contact us for personalized advice. Regarding costs, you can get a general range through cost estimation.

Recommendations for International Patients

TCM can serve as an effective adjunct in cancer treatment, but it must follow the principle of "safety first, evidence-based." Prioritize non-pharmacological therapies such as acupuncture and qigong, which have low risk and relatively sufficient evidence; for herbal medicine, use it only under professional guidance and with regular monitoring. At the same time, maintain rational expectations: TCM improves symptoms, not cures cancer. Work closely with your medical team so that TCM and modern medicine can each play to their strengths, jointly safeguarding your health.